ISIN | LU1048648130 |
---|---|
Valor Number | 25008424 |
Bloomberg Global ID | |
Fund Name | Swiss Rock Aktien Europa X |
Fund Provider |
Swiss Rock Asset Management AG
Zürich, Switzerland Phone: +41 44 360 57 00 E-Mail: info@swiss-rock.ch Web: www.swiss-rock.ch |
Fund Provider | Swiss Rock Asset Management AG |
Representative in Switzerland |
Swiss Rock Asset Management AG Zürich Phone: +41 44 360 57 00 |
Distributor(s) |
Swiss Rock Asset Management AG Zürich Phone: +41 44 360 57 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
Investment Strategy *** | Top tier performance in european equity with a rock solid investment approach, rotating investment styles. |
Peculiarities |
Current Price * | 23.99 EUR | 22.08.2025 |
---|---|---|
Previous Price * | 23.90 EUR | 21.08.2025 |
52 Week High * | 23.99 EUR | 22.08.2025 |
52 Week Low * | 19.74 EUR | 09.04.2025 |
NAV * | 23.99 EUR | 22.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 47,920,792 | |
Unit/Share Assets *** | 1,624,268 | |
Trading Information SIX |
YTD Performance | +14.46% |
31.12.2024 - 22.08.2025
31.12.2024 22.08.2025 |
---|---|---|
YTD Performance (in CHF) | +14.44% |
31.12.2024 - 22.08.2025
31.12.2024 22.08.2025 |
1 month | +3.27% |
22.07.2025 - 22.08.2025
22.07.2025 22.08.2025 |
3 months | +2.09% |
22.05.2025 - 22.08.2025
22.05.2025 22.08.2025 |
6 months | +4.67% |
24.02.2025 - 22.08.2025
24.02.2025 22.08.2025 |
1 year | +13.43% |
22.08.2024 - 22.08.2025
22.08.2024 22.08.2025 |
2 years | +36.77% |
22.08.2023 - 22.08.2025
22.08.2023 22.08.2025 |
3 years | +48.27% |
22.08.2022 - 22.08.2025
22.08.2022 22.08.2025 |
5 years | +83.27% |
24.08.2020 - 22.08.2025
24.08.2020 22.08.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 3.22% | |
---|---|---|
Novartis AG Registered Shares | 2.62% | |
ASML Holding NV | 2.37% | |
Novo Nordisk AS Class B | 2.03% | |
HSBC Holdings PLC | 1.94% | |
Siemens AG | 1.88% | |
Allianz SE | 1.67% | |
Unilever PLC | 1.63% | |
AstraZeneca PLC | 1.56% | |
Roche Holding AG | 1.46% | |
Last data update | 30.04.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 0.28% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |